Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN) and Alnylam Pharma (ALNY)
at www.tipranks.com (Thu, 12-Nov 2:40 AM)
Piper Sandler Sticks to Its Buy Rating for Alnylam Pharma (ALNY)
at www.tipranks.com (Tue, 10-Nov 6:56 AM)
Vir Biotechnology shares rise on hepatitis D therapy data
at seekingalpha.com (Mon, 9-Nov 9:55 AM)
Alnylam Sets Nov. 18 Webcast at Jefferies Healthcare Conference for 10:00 a.m. GMT
Market Chameleon (Wed, 4-Nov 9:05 AM)
Alnylam’s Q3 2026 revenue mix shifts: product sales rose 52% while collaboration revenue fell 80%
Market Chameleon (Thu, 29-Oct 8:38 AM)
